StocksFundsScreenerSectorsWatchlists
AGL

AGL - agilon health, inc. Stock Price, Fair Value and News

4.95USD-0.38 (-7.13%)Market Closed

Market Summary

AGL
USD4.95-0.38
Market Closed
-7.13%

AGL Stock Price

View Fullscreen

AGL RSI Chart

AGL Valuation

Market Cap

2.0B

Price/Earnings (Trailing)

-7.72

Price/Sales (Trailing)

0.47

EV/EBITDA

-11.36

Price/Free Cashflow

-11.78

AGL Price/Sales (Trailing)

AGL Profitability

EBT Margin

-4.51%

Return on Equity

-39.68%

Return on Assets

-15.08%

Free Cashflow Yield

-8.49%

AGL Fundamentals

AGL Revenue

Revenue (TTM)

4.3B

Rev. Growth (Yr)

120.54%

Rev. Growth (Qtr)

-32.92%

AGL Earnings

Earnings (TTM)

-262.6M

Earnings Growth (Yr)

-308.09%

Earnings Growth (Qtr)

-633.02%

Breaking Down AGL Revenue

Last 7 days

4.2%

Last 30 days

-6.6%

Last 90 days

-32.9%

Trailing 12 Months

-82.1%

How does AGL drawdown profile look like?

AGL Financial Health

Current Ratio

1.51

Debt/Equity

0.05

Debt/Cashflow

-4.83

AGL Investor Care

Buy Backs (1Y)

1.41%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.9B3.3B3.9B4.3B
20221.8B1.9B2.2B2.4B
20211.3B1.5B1.7B1.5B
2020900.4M1.0B1.1B1.2B
2019000794.4M
2018000474.8M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of agilon health, inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 14, 2024
desai veeral
bought
-
-
11,956
chief strategy & dev. officer
Mar 14, 2024
shaker benjamin
sold (taxes)
-498,241
5.23
-95,266
chief markets officer
Mar 14, 2024
kornitzer benjamin
sold (taxes)
-9,848
5.23
-1,883
chief med. & quality officer
Mar 14, 2024
shaker benjamin
bought
-
-
274,455
chief markets officer
Mar 14, 2024
desai veeral
sold (taxes)
-25,627
5.23
-4,900
chief strategy & dev. officer
Mar 14, 2024
venkatachaliah girish
sold (taxes)
-9,848
5.23
-1,883
chief technology officer
Mar 14, 2024
bensley timothy
sold (taxes)
-35,307
5.23
-6,751
chief financial officer
Mar 14, 2024
kornitzer benjamin
bought
-
-
5,434
chief med. & quality officer
Mar 14, 2024
venkatachaliah girish
bought
-
-
5,434
chief technology officer
Mar 14, 2024
bensley timothy
bought
-
-
14,945
chief financial officer

1–10 of 50

Which funds bought or sold AGL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 10, 2024
Yarbrough Capital, LLC
unchanged
-
-227,898
215,531
0.01%
Apr 09, 2024
Renaissance Capital LLC
added
2.99
-1,163,070
1,165,840
0.60%
Apr 05, 2024
GAMMA Investing LLC
added
911
8,591
9,498
-%
Apr 05, 2024
CWM, LLC
added
252
5,000
11,000
-%
Mar 27, 2024
NOMURA HOLDINGS INC
new
-
308,730
308,730
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-65.08
-12,641
4,142
-%
Mar 11, 2024
VANGUARD GROUP INC
added
0.78
-144,958,000
358,632,000
0.01%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
284
6,980,540
11,049,500
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-2.64
-26,427
58,270
-%
Feb 26, 2024
Neo Ivy Capital Management
new
-
47,000
47,000
0.10%

1–10 of 35

Are Funds Buying or Selling AGL?

Are funds buying AGL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AGL
No. of Funds

Unveiling agilon health, inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
7.04%
28,576,261
SC 13G
Feb 12, 2024
morgan stanley
10.8%
43,816,286
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Feb 09, 2024
capital world investors
13.6%
55,218,496
SC 13G/A
Feb 08, 2024
cd&r vector holdings, l.p.
24.6%
1e+08
SC 13G/A
Feb 08, 2024
wellington management group llp
10.47%
42,510,030
SC 13G/A
Sep 08, 2023
morgan stanley
10.7%
43,556,373
SC 13G/A
Sep 08, 2023
wellington management group llp
10.14%
41,124,989
SC 13G/A
Mar 10, 2023
capital world investors
10.3%
42,425,420
SC 13G/A
Feb 13, 2023
capital world investors
9.2%
37,918,473
SC 13G/A

Recent SEC filings of agilon health, inc.

View All Filings
Date Filed Form Type Document
Mar 18, 2024
4
Insider Trading
Mar 18, 2024
4
Insider Trading
Mar 18, 2024
4
Insider Trading
Mar 18, 2024
4
Insider Trading
Mar 18, 2024
4
Insider Trading
Feb 27, 2024
10-K
Annual Report
Feb 27, 2024
8-K
Current Report
Feb 13, 2024
SC 13G
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to agilon health, inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
404.6B
371.6B
-10.06% -16.60%
18.08
1.09
14.64% 11.24%
102.3B
195.3B
0.36% 32.66%
19.05
0.52
8.17% -20.79%
86.4B
357.8B
-8.56% -8.98%
10.34
0.24
10.95% 93.52%
85.4B
65.0B
0.28% 18.07%
16.29
1.31
7.86% -7.11%
37.8B
154.0B
-7.79% 1.99%
14
0.25
6.54% 124.79%
11.6B
14.3B
-4.37% 22.44%
16.11
0.81
6.59% 6.24%
11.4B
12.1B
-5.66% 54.55%
16.54
0.94
4.57% 23.40%
MID-CAP
9.4B
2.3B
-4.31% 9.94%
34.32
4.13
6.06% 9.17%
6.8B
2.9B
-6.65% -2.97%
-311.58
2.31
12.20% -107.93%
2.3B
1.4B
-0.51% 1.54%
37.23
1.63
21.19% 34.42%
2.1B
3.8B
-4.61% -35.19%
10.19
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
-1.23% -12.42%
25.41
1.5
11.31% 35.83%
1.2B
3.0B
4.69% 55.53%
-6.48
0.41
6.74% 20.73%
51.1M
-
-15.28% -9.77%
-3.49
-
- -12.94%
18.5M
21.3M
10.98% 5.02%
34.8
0.87
8.00% -62.25%

agilon health, inc. News

Latest updates
Morningstar25 hours ago
MarketBeat08 Apr 202406:32 pm

agilon health, inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Revenue-32.9%815,504,0001,215,660,0001,149,052,0001,136,147,000369,783,000694,858,000670,134,000653,445,000150,821,000458,613,000498,956,000413,104,000321,007,000312,684,000293,594,000291,048,000--
Costs and Expenses-22.9%975,106,0001,264,631,0001,178,873,000-423,848,000724,376,000691,186,000-----------
Operating Expenses----1,129,886,000758,892,000724,376,000691,186,000654,188,000510,759,000494,214,000797,319,000425,219,000360,750,000322,528,000294,846,000296,882,000--
  S&GA Expenses-14.6%63,277,00074,138,00081,499,00066,846,00064,051,00051,980,00051,924,00039,834,00025,521,00046,643,000317,561,00037,777,00045,581,50030,368,00034,248,00027,605,000--
EBITDA Margin-195.2%-0.04-0.01-0.02-0.02-0.03-0.04-0.04-0.18-0.21-0.22-0.22-0.03------
Interest Expenses14.2%1,886,0001,651,0001,588,0001,533,0001,668,0001,000,000945,000871,000840,000867,0001,498,0002,941,0001,953,0001,953,0002,080,0002,149,000--
Income Taxes-77.9%267,0001,210,0001,073,000-1,759,000572,000559,000580,000-71,000179,000256,000435,00016,000791,00035,00039,000---
Earnings Before Taxes-437.3%-162,667,000-30,273,000-15,722,00014,200,000-40,923,000-29,944,000-20,458,000655,000-35,625,000-36,737,000-296,894,000-13,720,000-38,810,000-12,266,000-3,406,000-7,861,000--
EBT Margin-139.8%-0.05-0.02-0.02-0.03-0.04-0.04-0.05-0.19-0.22-0.23-0.23-0.05------
Net Income-633.0%-230,433,000-31,436,000-16,749,00016,022,000-56,466,000-30,668,000-20,649,0001,230,000-56,721,000-35,843,000-298,845,000-15,078,000-24,215,000-11,827,000-7,911,000-16,099,000--
Net Income Margin-165.7%-0.06-0.02-0.02-0.03-0.04-0.04-0.05-0.19-0.22-0.22-0.23-0.04------
Free Cashflow-280.6%-65,098,000-17,105,000-25,298,000-64,528,000-53,448,000-786,000-64,718,000-27,282,000-52,297,000-21,661,000-39,759,000-41,006,000------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42019Q4
Assets-23.6%1,7412,2782,3532,1701,6971,8701,8411,8551,5861,6851,702574446403
  Current Assets-24.4%1,4801,9572,0451,8761,4511,6341,6011,6281,3671,4531,480418294246
    Cash Equivalents-36.1%1081681913944655646841,0221,0491,0821,109105128139
  Net PPE5.2%28.0026.0024.0022.0020.0018.0016.0013.009.006.005.005.006.007.00
  Goodwill-61.3%24.0062.0062.0062.003.0042.0042.0042.0042.0042.0042.0042.0042.0042.00
Liabilities-23.2%1,0801,4061,4731,088657785737744495558551563422354
  Current Liabilities-24.9%9771,3011,362973535658605610357423412372267200
  Long Term Debt-7.1%32.0035.0036.0037.0038.0040.0041.0042.0043.0045.0046.0099.0065.0067.00
    LT Debt, Current25.0%6.005.005.005.005.005.005.005.005.005.004.00-3.003.00
    LT Debt, Non Current-7.1%32.0035.0036.0037.0038.0040.0041.0042.0043.0045.0046.0099.0065.0067.00
Shareholder's Equity-24.1%6628728791,0821,0411,0851,1031,1111,0921,1271,150--284-
  Retained Earnings-21.0%-1,326-1,096-1,064-1,048-1,064-1,007-977-956-957-900-865-566-551-491
  Additional Paid-In Capital0.8%1,9871,9711,9472,1302,1072,0952,0762,0642,0462,0252,012266264257
Shares Outstanding0.1%406406405414412411407402373365352326--
Minority Interest-6.6%-0.82-0.77-0.72-0.67-0.61-0.53-0.46-0.37-0.30-0.28-0.17-0.07--
Float---5,200---4,500---6,600---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Cashflow From Operations-369.9%-61,166-13,018-21,204-60,811-49,9592,647-60,263-23,233-48,897-19,143-39,291-40,828-13,339-4,367-9,371-26,127--
  Share Based Compensation-25.2%15,51520,73619,57213,6729,9517,9076,5533,9704,41411,960274,5481,4721,8371,5582,1551,071--
Cashflow From Investing80.0%-2,203-11,03420,032-50,814-7,970-130,938-296,611-8,869-2,603-11,565-67,264-9,07423,2741,143-2,670319--
Cashflow From Financing-159.9%-8451,410-202,0378,3391,1309,1114,30913,50610,4178961,112,77930,298-760-6,1414,15427,368--
  Buy Backs-1,409-201,564----------6,742----

AGL Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:   
Total revenues$ 4,316,363$ 2,388,220$ 1,521,494
Expenses:   
General and administrative (including noncash stock-based compensation expense of $69,326, $28,069, and $291,672, respectively)285,760207,789427,502
Depreciation and amortization16,0438,94910,484
Total expenses4,548,4962,493,5981,893,736
Income (loss) from operations(232,133)(105,378)(372,242)
Other income (expense):   
Income (loss) from equity method investments16,48910,720(6,766)
Other income (expense), net27,84013,9302,178
Gain (loss) on lease terminations0(5,458)0
Interest expense(6,658)(4,484)(6,146)
Income (loss) before income taxes(194,462)(90,670)(382,976)
Income tax benefit (expense)(791)(1,640)(886)
Income (loss) from continuing operations(195,253)(92,310)(383,862)
Discontinued operations:   
Income (loss) before gain (loss) on sales and income taxes(20,002)(14,528)(25,085)
Gain (loss) on sales of assets, net(47,548)0473
Income tax benefit (expense)0(26)1,687
Total discontinued operations(67,550)(14,554)(22,925)
Net income (loss)(262,803)(106,864)(406,787)
Noncontrolling interests’ share in (earnings) loss207311300
Net income (loss) attributable to common shares$ (262,596)$ (106,553)$ (406,487)
Net income (loss) per common share, basic and diluted   
Continuing operations basic (in dollars per share)$ (0.48)$ (0.22)$ (1.03)
Continuing operations diluted (in dollars per share)(0.48)(0.22)(1.03)
Discontinued operations basic (in dollars per share)(0.16)(0.04)(0.06)
Discontinued operations diluted (in dollars per share)$ (0.16)$ (0.04)$ (0.06)
Weighted average shares outstanding, basic (in shares)408,917408,154372,931
Weighted average shares outstanding, diluted (in shares)408,917408,154372,931
Medical Services   
Revenues:   
Total revenues$ 4,307,350$ 2,384,889$ 1,518,322
Expenses:   
Expenses4,008,6592,093,8601,357,326
Other Operating   
Revenues:   
Total revenues9,0133,3313,172
Expenses:   
Expenses$ 238,034$ 183,000$ 98,424

AGL Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 107,570$ 465,302
Restricted cash and equivalents6,75910,610
Marketable securities380,773411,901
Receivables, net942,461492,364
Prepaid expenses and other current assets, net42,51331,572
Current assets of discontinued operations039,525
Total current assets1,480,0761,451,274
Property and equipment, net27,57619,937
Intangible assets, net63,76918,448
Goodwill24,1332,513
Other assets145,312105,861
Non-current assets of discontinued operations099,435
Total assets1,740,8661,697,468
Current liabilities:  
Medical claims and related payables737,724300,798
Accounts payable and accrued expenses233,182177,428
Current portion of long-term debt6,2505,000
Current liabilities of discontinued operations051,865
Total current liabilities977,156535,091
Long-term debt, net of current portion32,30838,482
Other liabilities70,38182,492
Non-current liabilities of discontinued operations0794
Total liabilities1,079,845656,859
Commitments and contingencies
Stockholders' equity (deficit):  
Common stock, $0.01 par value: 2,000,000 shares authorized; 406,387 and 412,385 shares issued and outstanding, respectively4,0644,124
Additional paid-in capital1,986,8992,106,886
Accumulated deficit(1,326,826)(1,064,230)
Accumulated other comprehensive income (loss)(2,298)(5,560)
Total agilon health, inc. stockholders' equity (deficit)661,8391,041,220
Noncontrolling interests(818)(611)
Total stockholders’ equity (deficit)661,0211,040,609
Total liabilities and stockholders’ equity (deficit)$ 1,740,866$ 1,697,468
AGL
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
 CEO
 WEBSITEagilonhealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES747

agilon health, inc. Frequently Asked Questions


What is the ticker symbol for agilon health, inc.? What does AGL stand for in stocks?

AGL is the stock ticker symbol of agilon health, inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of agilon health, inc. (AGL)?

As of Fri Apr 12 2024, market cap of agilon health, inc. is 2.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers. The fair value of agilon health, inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of agilon health, inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AGL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is agilon health, inc. a good stock to buy?

The fair value guage provides a quick view whether AGL is over valued or under valued. Whether agilon health, inc. is cheap or expensive depends on the assumptions which impact agilon health, inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AGL.

What is agilon health, inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, AGL's PE ratio (Price to Earnings) is -7.72 and Price to Sales (PS) ratio is 0.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AGL PE ratio will change depending on the future growth rate expectations of investors.